Sergio Szyldergemajn
- Co-authors
- Carmen KahattMartín Cullell-YoungMariano SigueroMark J. RatainSoonmo Peter KangTeresa MacarullaJosep TaberneroMaría Elena Elez
- Topics
- Cancer Treatment and Pharmacology (10 papers)Lung Cancer Research Studies (10 papers)Cancer therapeutics and mechanisms (9 papers)
- Cited by
- BiotechnologyOncologyCancer Research
- Partner nations
- SpainFranceUnited States
In The Last Decade
Sergio Szyldergemajn
36 papers receiving 378 citations
Peers
Comparison fields: 5 of 52
- Molecular Biology 219
- Oncology 167
- Pulmonary and Respiratory Medicine 77
- Biotechnology 56
- Cancer Research 53
Countries citing papers authored by Sergio Szyldergemajn
This map shows the geographic impact of Sergio Szyldergemajn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Szyldergemajn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Szyldergemajn more than expected).
Fields of papers citing papers by Sergio Szyldergemajn
This network shows the impact of papers produced by Sergio Szyldergemajn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Szyldergemajn. The network helps show where Sergio Szyldergemajn may publish in the future.
Co-authorship network of co-authors of Sergio Szyldergemajn
This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Szyldergemajn. A scholar is included among the top collaborators of Sergio Szyldergemajn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Szyldergemajn. Sergio Szyldergemajn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 17 | |
| 6 | 2 | |
| 7 | 20 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 23 | |
| 12 | 52 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 11 | |
| 16 | 2 | |
| 17 | 61 | |
| 18 | 3 | |
| 19 | 24 | |
| 20 | 4 |
About Sergio Szyldergemajn
Sergio Szyldergemajn is a scholar working on Oncology, Otorhinolaryngology and Cancer Research, having authored 36 papers that have together received 383 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Lung Cancer Research Studies (10 papers) and Cancer therapeutics and mechanisms (9 papers). The work is most often cited by research in Biotechnology (56 citations), Oncology (167 citations) and Cancer Research (53 citations). Sergio Szyldergemajn has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Carmen Kahatt, Martín Cullell-Young, Mariano Siguero, Mark J. Ratain, Soonmo Peter Kang, Teresa Macarulla, Josep Tabernero, María Elena Elez, Claudia Corrado and Emanuele Zucca. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.